Document is current
Any future updates will be listed below
-
Authors
Nixon, Briana G. http://orcid.org/0000-0001-7334-9404
Gao, Shengyu http://orcid.org/0000-0003-2844-6306
Wang, Xinxin
Li, Ming O. http://orcid.org/0000-0002-1383-0535
- License Information
-
More Information
Article History
Accepted: 10 October 2022
First Online: 15 November 2022
Competing interests
: Memorial Sloan Kettering Cancer Center holds a patent entitled “Methods and compositions for targeting TGF-β signalling in CD4<sup>+</sup> helper T cells for cancer immunotherapy” with M.O.L. listed as an inventor. The other authors declare no competing interests.
